2025
Potential Clinical and Economic Impacts of Cutbacks in the President's Emergency Plan for AIDS Relief Program in South Africa : A Modeling Analysis.
Gandhi A, Bekker L, Paltiel A, Hyle E, Ciaranello A, Pillay Y, Freedberg K, Neilan A. Potential Clinical and Economic Impacts of Cutbacks in the President's Emergency Plan for AIDS Relief Program in South Africa : A Modeling Analysis. Annals Of Internal Medicine 2025, 178: 457-467. PMID: 39932732, PMCID: PMC11996594, DOI: 10.7326/annals-24-01104.Peer-Reviewed Original ResearchPresident's Emergency PlanPEPFAR fundingHIV diagnosis ratesClinical HIV outcomesHIV care continuumSouth African adultsNational Institutes of HealthCare continuumHIV outcomesHIV programsAIDS ReliefHIV prevalenceInstitutes of HealthPrimary preventionTreatment engagementEmergency planningPEPFARLife yearsPWHAfrican adultsHIV budgetLife expectancyLong-term detrimental effectsDiagnosis rateProgrammatic implications
2024
A Scoping Review of Factors Associated with HIV Acquisition in the Context of Humanitarian Crises
Harsono D, Atre S, Peterson H, Nyhan K, Garmroudi D, Davis J, Ho W, Khoshnood K. A Scoping Review of Factors Associated with HIV Acquisition in the Context of Humanitarian Crises. AIDS And Behavior 2024, 28: 4224-4273. PMID: 39292318, DOI: 10.1007/s10461-024-04504-x.Peer-Reviewed Original ResearchFactors associated with HIV acquisitionHIV acquisitionContext of humanitarian crisesHumanitarian crisisHIV prevalenceUptake of HIV prevention strategiesJoanna Briggs Institute methodologyCulturally appropriate HIV prevention interventionsSexually transmitted infection diagnosisMeta-Analysis extensionHIV prevention interventionsSocial ecological modelHIV prevention strategiesNon-modifiable factorsRisk factorsVulnerability to HIV infectionPreferred Reporting ItemsExperience of rapeInternally displaced personsNon-government organizationsMultilevel barriersSingle-country studiesInstitute methodologyCommunity healthHealth servicesDesign and implementation of a Type-2 hybrid, prospective randomized trial of opioid agonist therapies integration into primary care clinics in Ukraine
Machavariani E, Dumchev K, Pykalo I, Filippovych M, Ivasiy R, Esserman D, Madden L, Bromberg D, Haddad M, Morozova O, Ahmad B, Gómez D, Farnum S, Dvoriak S, Altice F. Design and implementation of a Type-2 hybrid, prospective randomized trial of opioid agonist therapies integration into primary care clinics in Ukraine. Contemporary Clinical Trials 2024, 146: 107690. PMID: 39265780, PMCID: PMC11531372, DOI: 10.1016/j.cct.2024.107690.Peer-Reviewed Original ResearchPrimary care centersQuality health indicatorsNon-communicable diseasesSpecialty treatment centersOpioid agonist therapyImplementation of integrated carePay-for-performance incentivesPrimary care clinicsPrimary care settingSelf-reported prevalencePay-for-performancePrevalence of medical comorbiditiesParticipants self-reportedEffective evidence-based treatmentsHealth of PWIDEvidence-based treatmentsIntegrated careCare clinicsImplementation outcomesImplementation trialCare settingsElectronic chart reviewHigh-burden countriesSpecialty servicesHIV prevalenceHealth-seeking behaviour and patient-related factors associated with the time to TB treatment initiation in four African countries: a cross-sectional survey
Sathar F, Charalambous S, Velen K, Fielding K, Rachow A, Ivanova O, Rassool M, Lalashowi J, Owolabi O, Nhassengo P, Chihota V, Evans D. Health-seeking behaviour and patient-related factors associated with the time to TB treatment initiation in four African countries: a cross-sectional survey. BMJ Public Health 2024, 2: e001002. PMID: 40018527, PMCID: PMC11816287, DOI: 10.1136/bmjph-2024-001002.Peer-Reviewed Original ResearchTB treatment initiationCross-sectional surveyTB symptomsPrimary care facilitiesTreatment initiationMedian total delayHealth-seeking behaviorNational TB Control ProgrammeTB treatmentCohort of adultsTB control programmesActive case findingPatient-related factorsHealth facilitiesTB servicesHIV prevalenceCare facilitiesDrug-susceptible pulmonary TBTotal delaySecond-leading causeTime to treatment initiationCase findingCox regression modelsStructured questionnaireInitiation of treatmentQualitative description of interpersonal HIV stigma and motivations for HIV testing among gays, bisexuals, and men who have sex with men in Ghana’s slums—BSGH-005
Abu-Ba’are G, Shamrock O, Zigah E, Ogunbajo A, Dakpui H, Agbemedu G, Boyd D, Ezechi O, Nelson L, Torpey K. Qualitative description of interpersonal HIV stigma and motivations for HIV testing among gays, bisexuals, and men who have sex with men in Ghana’s slums—BSGH-005. PLOS ONE 2024, 19: e0289905. PMID: 38837972, PMCID: PMC11152275, DOI: 10.1371/journal.pone.0289905.Peer-Reviewed Original ResearchConceptsHIV testingHIV stigmaHIV testing servicesLevel of stigmaFace-to-face interviewsHIV education interventionsHIV knowledge levelsSummative content analysisGBMSM livingEducational interventionHIV preventionHealthcare servicesHIV prevalenceCommunity partnersHIV responseTesting servicesHIV statusHIV vulnerabilityGBMSMSexual healthStigmaKnowledge levelContent analysisHIVSlumsThe impact of emergency guidance to the COVID‐19 pandemic on treatment entry, retention and mortality among patients on methadone in Ukraine
Ivasiy R, Madden L, Meteliuk A, Machavariani E, Ahmad B, Zelenev A, Desai M, Bromberg D, Polonsky M, de Leon S, Farnum S, Islam Z, Altice F. The impact of emergency guidance to the COVID‐19 pandemic on treatment entry, retention and mortality among patients on methadone in Ukraine. Addiction 2024, 119: 1585-1596. PMID: 38807448, DOI: 10.1111/add.16565.Peer-Reviewed Original ResearchOpioid agonist therapyTake-home dosesCOVID-19 guidancePre-COVID cohortAgonist therapyOptimal doseTreatment retentionEmergency guidanceEffective HIV prevention strategiesAdult HIV prevalenceHIV prevention strategiesMinistry of HealthImprove treatment retentionMethadone dosePatient survivalTime-dependent predictorsProspective cohortHIV prevalencePredictors of treatment retentionGovernmental clinicsPrimary outcomeHazard ratioPatient enrollmentPatientsMethadone patientsModeled estimates of HIV-serodifferent couples in tuberculosis-affected households in four sub-Saharan African countries
Zhang M, Tseng A, Anguzu G, Barnabas R, Davis J, Mujugira A, Flaxman A, Ross J. Modeled estimates of HIV-serodifferent couples in tuberculosis-affected households in four sub-Saharan African countries. PLOS Global Public Health 2024, 4: e0002609. PMID: 38696500, PMCID: PMC11065259, DOI: 10.1371/journal.pgph.0002609.Peer-Reviewed Original ResearchHIV serodifferent couplesTB-affected householdsSerodifferent couplesPrEP useSub-Saharan African countriesHIV acquisitionSouth AfricaGeneral populationHIV prevalencePopulation-based household surveyOral pre-exposure prophylaxisPre-exposure prophylaxisGlobal Burden of DiseaseHousehold surveyRisk Factors StudyAfrican countriesBurden of diseaseHouseholdsHigh-burden countriesContact evaluationPrEPGlobal burdenCountriesMeta-analysesTB-HIVExploring the syndemic interaction between social, environmental and structural contexts of HIV infection in peri-mining areas in South Africa: a qualitative study
Chimoyi L, Ndini P, Oladimeji M, Seatlholo N, Mawokomatanda K, Charalambous S, Setswe G. Exploring the syndemic interaction between social, environmental and structural contexts of HIV infection in peri-mining areas in South Africa: a qualitative study. BMJ Open 2024, 14: e076198. PMID: 38521520, PMCID: PMC10961556, DOI: 10.1136/bmjopen-2023-076198.Peer-Reviewed Original ResearchConceptsFemale sex workersFocus group discussionsIn-depth interviewsInjection drug usersUptake of HIV prevention servicesHealthcare workersHIV prevention servicesHIV infectionHIV prevention programmesPre-exposure prophylaxisAssociated with HIV acquisitionAccessibility to alcoholSocio-behavioral factorsCommunity-based organisationsPreventive servicesHIV prevalencePrevention programmesAreas of South AfricaSyndemic factorsQualitative studyHIV transmissionHIV acquisitionInclusion criteriaFactors affecting peopleSex workers
2023
Transmission modeling to infer tuberculosis incidence prevalence and mortality in settings with generalized HIV epidemics
Dodd P, Shaweno D, Ku C, Glaziou P, Pretorius C, Hayes R, MacPherson P, Cohen T, Ayles H. Transmission modeling to infer tuberculosis incidence prevalence and mortality in settings with generalized HIV epidemics. Nature Communications 2023, 14: 1639. PMID: 36964130, PMCID: PMC10037365, DOI: 10.1038/s41467-023-37314-1.Peer-Reviewed Original ResearchConceptsHigh HIV prevalence settingsEstimation of burdenHIV prevalence settingsGeneralized HIV epidemicsTB transmission modelAntiretroviral therapyTB infectionTB incidenceHIV prevalenceTB prevalencePrevalence settingsTB epidemicHIV epidemicHigh burdenBurden estimatesNotification dataAnnual riskSingle pathogenIntervention impactTherapy effectsTuberculosisPrevalenceEpidemicBurdenAfrican countriesSubstance use and other correlates of HIV infection among transwomen and men who have sex with men in Perú: Implications for targeted HIV prevention strategies for transwomen
Cyrus E, Lama J, Sanchez J, Sullivan D, Leon S, Villaran M, Vagenas P, Vu D, Coudray M, Altice F. Substance use and other correlates of HIV infection among transwomen and men who have sex with men in Perú: Implications for targeted HIV prevention strategies for transwomen. PLOS Global Public Health 2023, 3: e0001464. PMID: 36962933, PMCID: PMC10022005, DOI: 10.1371/journal.pgph.0001464.Peer-Reviewed Original ResearchHIV risk factorsRisk factorsHIV riskSubstance usePrevention strategiesCross-sectional biobehavioral surveyHIV prevention strategiesTargeted prevention strategiesDifferent risk factorsSubstance use patternsBinary logistic regressionHIV infectionHIV prevalenceBiobehavioral surveysHigh prevalenceChi-square analysisSecondary data analysisHigh riskDrug useAlcohol dependenceCocaine useLogistic regressionMSMClinical researchRelated correlates
2022
Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000–2018
Haeuser E, Serfes A, Cork M, Yang M, Abbastabar H, Abhilash E, Adabi M, Adebayo O, Adekanmbi V, Adeyinka D, Afzal S, Ahinkorah B, Ahmadi K, Ahmed M, Akalu Y, Akinyemi R, Akunna C, Alahdab F, Alanezi F, Alanzi T, Alene K, Alhassan R, Alipour V, Almasi-Hashiani A, Alvis-Guzman N, Ameyaw E, Amini S, Amugsi D, Ancuceanu R, Anvari D, Appiah S, Arabloo J, Aremu O, Asemahagn M, Jafarabadi M, Awedew A, Quintanilla B, Ayanore M, Aynalem Y, Azari S, Azene Z, Darshan B, Babalola T, Baig A, Banach M, Bärnighausen T, Bell A, Bhagavathula A, Bhardwaj N, Bhardwaj P, Bhattacharyya K, Bijani A, Bitew Z, Bohlouli S, Bolarinwa O, Boloor A, Bozicevic I, Butt Z, Cárdenas R, Carvalho F, Charan J, Chattu V, Chowdhury M, Chu D, Cowden R, Dahlawi S, Damiani G, Darteh E, Darwesh A, das Neves J, Weaver N, De Leo D, De Neve J, Deribe K, Deuba K, Dharmaratne S, Dianatinasab M, Diaz D, Didarloo A, Djalalinia S, Dorostkar F, Dubljanin E, Duko B, El Tantawi M, El-Jaafary S, Eshrati B, Eskandarieh S, Eyawo O, Ezeonwumelu I, Ezzikouri S, Farzadfar F, Fattahi N, Fauk N, Fernandes E, Filip I, Fischer F, Foigt N, Foroutan M, Fukumoto T, Gad M, Gaidhane A, Gebregiorgis B, Gebremedhin K, Getacher L, Ghadiri K, Ghashghaee A, Golechha M, Gubari M, Gugnani H, Guimarães R, Haider M, Haj-Mirzaian A, Hamidi S, Hashi A, Hassanipour S, Hassankhani H, Hayat K, Herteliu C, Ho H, Holla R, Hosseini M, Hosseinzadeh M, Hwang B, Ibitoye S, Ilesanmi O, Ilic I, Ilic M, Islam R, Iwu C, Jakovljevic M, Jha R, Ji J, Johnson K, Joseph N, Joshua V, Joukar F, Jozwiak J, Kalankesh L, Kalhor R, Kamyari N, Kanchan T, Matin B, Karimi S, Kayode G, Karyani A, Keramati M, Khan E, Khan G, Khan M, Khatab K, Khubchandani J, Kim Y, Kisa A, Kisa S, Kopec J, Kosen S, Laxminarayana S, Koyanagi A, Krishan K, Defo B, Kugbey N, Kulkarni V, Kumar M, Kumar N, Kusuma D, La Vecchia C, Lal D, Landires I, Larson H, Lasrado S, Lee P, Li S, Liu X, Maleki A, Malik P, Mansournia M, Martins-Melo F, Mendoza W, Menezes R, Mengesha E, Meretoja T, Mestrovic T, Mirica A, Moazen B, Mohamad O, Mohammad Y, Mohammadian-Hafshejani A, Mohammadpourhodki R, Mohammed S, Mohammed S, Mokdad A, Moradi M, Moraga P, Mubarik S, Mulu G, Mwanri L, Nagarajan A, Naimzada M, Naveed M, Nazari J, Ndejjo R, Negoi I, Ngalesoni F, Nguefack-Tsague G, Ngunjiri J, Nguyen C, Nguyen H, Nnaji C, Noubiap J, Nuñez-Samudio V, Nwatah V, Oancea B, Odukoya O, Olagunju A, Olakunde B, Olusanya B, Olusanya J, Bali A, Onwujekwe O, Orisakwe O, Otstavnov N, Otstavnov S, Owolabi M, Mahesh P, Padubidri J, Pana A, Pandey A, Pandi-Perumal S, Kan F, Patton G, Pawar S, Peprah E, Postma M, Preotescu L, Syed Z, Rabiee N, Radfar A, Rafiei A, Rahim F, Rahimi-Movaghar V, Rahmani A, Ramezanzadeh K, Rana J, Ranabhat C, Rao S, Rawaf D, Rawaf S, Rawassizadeh R, Regassa L, Rezaei N, Rezapour A, Riaz M, Ribeiro A, Ross J, Rubagotti E, Rumisha S, Rwegerera G, Moghaddam S, Sagar R, Sahiledengle B, Sahu M, Salem M, Kafil H, Samy A, Sartorius B, Sathian B, Seidu A, Shaheen A, Shaikh M, Shamsizadeh M, Shiferaw W, Shin J, Shrestha R, Singh J, Skryabin V, Skryabina A, Soltani S, Sufiyan M, Tabuchi T, Tadesse E, Taveira N, Tesfay F, Thapar R, Tovani-Palone M, Tsegaye G, Umeokonkwo C, Unnikrishnan B, Villafañe J, Violante F, Vo B, Vu G, Wado Y, Waheed Y, Wamai R, Wang Y, Ward P, Wickramasinghe N, Wilson K, Yaya S, Yip P, Yonemoto N, Yu C, Zastrozhin M, Zhang Y, Zhang Z, Hay S, Dwyer-Lindgren L. Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000–2018. BMC Medicine 2022, 20: 488. PMID: 36529768, PMCID: PMC9760541, DOI: 10.1186/s12916-022-02639-z.Peer-Reviewed Original ResearchConceptsHIV prevalenceAge groupsBackgroundHuman immunodeficiency virusJoint United Nations ProgrammeImmune deficiency syndromeHIV prevalence estimatesAdults ages 15HIV/AIDSClinic attendeesUnited Nations ProgrammeImmunodeficiency virusSentinel surveillanceDisease burdenDeficiency syndromePrevalence increasesSeroprevalence surveyPrevalence trendsLow prevalencePrevalence estimatesTreatment interventionsPrevalence differencesTargeted interventionsPrevalenceTreatment effortsAge 15Does Voluntary Medical Male Circumcision Reduce HIV Risk in Men Who Have Sex with Men?
Lin Y, Gao Y, Sun Y, Turner D, Zou H, Vermund S, Qian H. Does Voluntary Medical Male Circumcision Reduce HIV Risk in Men Who Have Sex with Men? Current HIV/AIDS Reports 2022, 19: 522-525. PMID: 36520379, DOI: 10.1007/s11904-022-00637-7.Peer-Reviewed Original ResearchConceptsVoluntary medical male circumcisionRandomized clinical trialsHIV riskMedical male circumcisionPurpose of ReviewToSubgroup of menHIV prevalenceClinical trialsAnal sexMale circumcisionPopulation-level impactAvailable evidenceMSMInsertive roleConflicting resultsMenSexRiskOriginal studyEfficacyInterventionEvidenceReviewToStrong evidencePrevalenceVoluntary Medical Male Circumcision to Reduce HIV Acquisition and Transmission
Vermund S. Voluntary Medical Male Circumcision to Reduce HIV Acquisition and Transmission. Current HIV/AIDS Reports 2022, 19: 471-473. PMID: 36478080, PMCID: PMC10767716, DOI: 10.1007/s11904-022-00631-z.Peer-Reviewed Original ResearchConceptsHIV acquisitionVoluntary medical male circumcisionHIV infection acquisitionVoluntary medical male circumcision (VMMC) programsMinor surgical interventionsMale circumcision programsHIV incidence ratesHigh HIV prevalenceMedical male circumcisionFirst clinical trialUninfected menHIV incidenceHIV prevalenceInfection acquisitionSaharan AfricaSurgical interventionCircumcision programsClinical trialsIncidence ratePreventive benefitsHIV riskCircumcision ratesRecent FindingsSinceMale circumcisionHealth sectionA cross-sectional investigation of HIV prevalence and risk factors among African, Caribbean and Black people in Ontario: The A/C Study
Mbuagbaw L, Husbands W, Baidoobonso S, Lawson D, Aden M, Etowa J, Nelson L, Tharao W. A cross-sectional investigation of HIV prevalence and risk factors among African, Caribbean and Black people in Ontario: The A/C Study. Relevé Des Maladies Transmissibles Au Canada 2022, 48: 429-437. PMID: 38125394, PMCID: PMC10730175, DOI: 10.14745/ccdr.v48i10a03.Peer-Reviewed Original ResearchPositive HIV testACB peopleHIV infectionHIV testHIV prevalenceHuman immunodeficiency virus (HIV) infectionHuman immunodeficiency virus (HIV) epidemicSelf-reported HIV statusImmunodeficiency virus infectionBlood spot testingCross-sectional surveyCross-sectional investigationHIV statusRisk factorsVirus infectionHigher ageSociodemographic informationAdult populationInfectionPrevalenceSubstance useVirus epidemicBehavioral factorsSpot testingBisexual orientation
2021
HIV prevalence among non‐injecting people who use drugs and related factors in Iran: A systematic review and meta‐analysis
Gholami J, Rostam‐Abadi Y, Rahimi Y, Fotouhi A, Amin‐Esmaeili M, Rahimi‐Movaghar A. HIV prevalence among non‐injecting people who use drugs and related factors in Iran: A systematic review and meta‐analysis. Drug And Alcohol Review 2021, 41: 666-676. PMID: 34783411, DOI: 10.1111/dar.13407.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virus prevalenceHuman immunodeficiency virusOdds of HIV infectionHIV infectionSystematic reviewPrevalence of human immunodeficiency virusPrevalence of HIV infectionReduce HIV prevalenceRandom-effects modelCitation trackingHIV prevalenceImmunodeficiency virusNo significant differenceHarm reductionPWUDGeneral populationUnpublished studiesGender subgroupsComprehensive searchNational databaseMeta-analysisSignificant differencePrevalencePreventive measuresInfectionHIV care continuum among cisgender and transgender women sex workers in Greater Kuala Lumpur, Malaysia
Ranjit YS, Gibson BA, Altice FL, Kamarulzaman A, Azwa I, Wickersham JA. HIV care continuum among cisgender and transgender women sex workers in Greater Kuala Lumpur, Malaysia. AIDS Care 2021, 35: 784-790. PMID: 34723714, PMCID: PMC9056582, DOI: 10.1080/09540121.2021.1995839.Peer-Reviewed Original ResearchConceptsTransgender women sex workersHIV care continuumAntiretroviral treatmentSex workersCare continuumWomen sex workersTransgender womenImportant key populationProportion of womenRespondent-driven sampling studyEvidence-based strategiesAntiretroviral therapyHIV careHIV prevalenceHIV epidemicHIVKey populationsWomenKuala LumpurCisgender womenCount testUnique needsSmall proportionTherapyPopulationCongenital Cytomegalovirus Infection Burden and Epidemiologic Risk Factors in Countries With Universal Screening
Ssentongo P, Hehnly C, Birungi P, Roach M, Spady J, Fronterre C, Wang M, Murray-Kolb L, Al-Shaar L, Chinchilli V, Broach J, Ericson J, Schiff S. Congenital Cytomegalovirus Infection Burden and Epidemiologic Risk Factors in Countries With Universal Screening. JAMA Network Open 2021, 4: e2120736. PMID: 34424308, PMCID: PMC8383138, DOI: 10.1001/jamanetworkopen.2021.20736.Peer-Reviewed Original ResearchConceptsPrevalence of cCMVHigh-income countriesBirth prevalenceUniversal screeningInfection burdenHIV prevalenceRisk factorsBlood samplesCommon congenital infectionMaternal CMV seroprevalenceCongenital cytomegalovirus infectionEpidemiologic risk factorsPooled overall prevalenceNewcastle-Ottawa ScaleSystematic Reviews databasesMeta-Analyses (PRISMA) guidelinesPooled birth prevalenceMEDLINE/PubMedPreferred Reporting ItemsLow socioeconomic statusWorld Bank income levelsLower ratesCMV seroprevalenceCongenital infectionCohort studyHepatitis B, Hepatitis C, tuberculosis and sexually-transmitted infections among HIV positive patients in Kazakhstan
Mukhatayeva A, Mustafa A, Dzissyuk N, Issanov A, Bayserkin B, Vermund SH, Ali S. Hepatitis B, Hepatitis C, tuberculosis and sexually-transmitted infections among HIV positive patients in Kazakhstan. Scientific Reports 2021, 11: 13542. PMID: 34188081, PMCID: PMC8241865, DOI: 10.1038/s41598-021-92688-w.Peer-Reviewed Original ResearchConceptsStudy participantsHepatitis CHepatitis BRegular screeningHIV-positive study participantsHCV/HBVHIV-positive patientsTB/HIVHIV/HCVDirect acting antiviralsHIV/tuberculosisOpiate substitution therapyInjection drug useHarm reduction effortsAvailability of ARTHCV infectionTB infectionActing antiviralsCertain age groupsPositive patientsHIV infectionHIV prevalenceSubstitution therapyVaccination protocolsQuadruple infectionsSubnational mapping of HIV incidence and mortality among individuals aged 15–49 years in sub-Saharan Africa, 2000–18: a modelling study
Collaborators L, Sartorius B, VanderHeide J, Yang M, Goosmann E, Hon J, Haeuser E, Cork M, Perkins S, Jahagirdar D, Schaeffer L, Serfes A, LeGrand K, Abbastabar H, Abebo Z, Abosetugn A, Abu-Gharbieh E, Accrombessi M, Adebayo O, Adegbosin A, Adekanmbi V, Adetokunboh O, Adeyinka D, Ahinkorah B, Ahmadi K, Ahmed M, Akalu Y, Akinyemi O, Akinyemi R, Aklilu A, Akunna C, Alahdab F, Al-Aly Z, Alam N, Alamneh A, Alanzi T, Alemu B, Alhassan R, Ali T, Alipour V, Amini S, Ancuceanu R, Ansari F, Anteneh Z, Anvari D, Anwer R, Appiah S, Arabloo J, Asemahagn M, Jafarabadi M, Asmare W, Atnafu D, Atout M, Atreya A, Ausloos M, Awedew A, Quintanilla B, Ayanore M, Aynalem Y, Ayza M, Azari S, Azene Z, Babar Z, Baig A, Balakrishnan S, Banach M, Bärnighausen T, Basu S, Bayati M, Bedi N, Bekuma T, Bezabhe W, Bhagavathula A, Bhardwaj P, Bhattacharyya K, Bhutta Z, Bibi S, Bikbov B, Birhan T, Bitew Z, Bockarie M, Boloor A, Brady O, Bragazzi N, Briko A, Briko N, Nagaraja S, Butt Z, Cárdenas R, Carvalho F, Charan J, Chatterjee S, Chattu S, Chattu V, Chowdhury M, Chu D, Cook A, Cormier N, Cowden R, Culquichicon C, Dagnew B, Dahlawi S, Damiani G, Daneshpajouhnejad P, Daoud F, Daryani A, Neves J, Weaver N, Molla M, Deribe K, Desta A, Deuba K, Dharmaratne S, Dhungana G, Diaz D, Djalalinia S, Doku P, Dubljanin E, Duko B, Eagan A, Earl L, Eaton J, Effiong A, Zaki M, Tantawi M, Elayedath R, El-Jaafary S, Elsharkawy A, Eskandarieh S, Eyawo O, Ezzikouri S, Fasanmi A, Fasil A, Fauk N, Feigin V, Ferede T, Fernandes E, Fischer F, Foigt N, Folayan M, Foroutan M, Francis J, Fukumoto T, Gad M, Geberemariyam B, Gebregiorgis B, Gebremichael B, Gesesew H, Getacher L, Ghadiri K, Ghashghaee A, Gilani S, Ginindza T, Glagn M, Golechha M, Gona P, Gubari M, Gugnani H, Guido D, Guled R, Hall B, Hamidi S, Handiso D, Hargono A, Hashi A, Hassanipour S, Hassankhani H, Hayat K, Herteliu C, de Hidru H, Holla R, Hosgood H, Hossain N, Hosseini M, Hosseinzadeh M, Househ M, Hwang B, Ibitoye S, Ilesanmi O, Ilic I, Ilic M, Irvani S, Iwu C, Iwu C, Iyamu I, Jain V, Jakovljevic M, Jalilian F, Jha R, Johnson K, Joshua V, Joukar F, Jozwiak J, Kabir A, Kalankesh L, Kalhor R, Kamath A, Kamyari N, Kanchan T, Matin B, Karch A, Karimi S, Kasa A, Kassahun G, Kayode G, Karyani A, Keiyoro P, Kelkay B, Khalid N, Khan G, Khan J, Khan N, Khatab K, Khazaei S, Kim Y, Kisa A, Kisa S, Kochhar S, Kopec J, Kosen S, Laxminarayana S, Koyanagi A, Krishan K, Defo B, Kugbey N, Kulkarni V, Kumar M, Kumar N, Kurmi O, Kusuma D, Kuupiel D, Kyu H, La Vecchia C, Lal D, Lam J, Landires I, Lasrado S, Lazarus J, Lazzar-Atwood A, Lee P, Leshargie C, Li B, Liu X, Lopukhov P, Amin H, Madi D, Mahasha P, Majeed A, Maleki A, Maleki S, Mamun A, Manafi N, Mansournia M, Martins-Melo F, Masoumi S, Mayala B, Meharie B, Meheretu H, Meles H, Melku M, Mendoza W, Mengesha E, Meretoja T, Mersha A, Mestrovic T, Miller T, Mirica A, Mirzaei-Alavijeh M, Mohamad O, Mohammad Y, Mohammadian-Hafshejani A, Mohammed J, Mohammed S, Mohammed S, Mokdad A, Mokonnon T, Molokhia M, Moradi M, Moradi Y, Moradzadeh R, Moraga P, Mosser J, Munro S, Mustafa G, Muthupandian S, Naderi M, Nagarajan A, Naghavi M, Naveed M, Nayak V, Nazari J, Ndejjo R, Nepal S, Netsere H, Ngalesoni F, Nguefack-Tsague G, Ngunjiri J, Nigatu Y, Nigussie S, Nnaji C, Noubiap J, Nuñez-Samudio V, Oancea B, Odukoya O, Ogbo F, Oladimeji O, Olagunju A, Olusanya B, Olusanya J, Omer M, Omonisi A, Onwujekwe O, Orisakwe O, Otstavnov N, Owolabi M, Mahesh P, Padubidri J, Pakhale S, Pana A, Pandi-Perumal S, Patel U, Pathak M, Patton G, Pawar S, Peprah E, Pokhrel K, Postma M, Pottoo F, Pourjafar H, Pribadi D, Syed Z, Rafiei A, Rahim F, Rahman M, Rahmani A, Ram P, Rana J, Ranabhat C, Rao S, Rao S, Rathi P, Rawaf D, Rawaf S, Rawassizadeh R, Renjith V, Reta M, Rezaei N, Rezapour A, Ribeiro A, Ross J, Rumisha S, Sagar R, Sahu M, Sajadi S, Salem M, Samy A, Sathian B, Schutte A, Seidu A, Sha F, Shafaat O, Shahbaz M, Shaikh M, Shaka M, Sheikh A, Shibuya K, Shin J, Shivakumar K, Sidemo N, Singh J, Skryabin V, Skryabina A, Soheili A, Soltani S, Somefun O, Sorrie M, Spurlock E, Sufiyan M, Taddele B, Tadesse E, Tamir Z, Tamiru A, Tanser F, Taveira N, Tehrani-Banihashemi A, Tekalegn Y, Tesfay F, Tessema B, Tessema Z, Thakur B, Tolani M, Topor-Madry R, Torrado M, Tovani-Palone M, Traini E, Tsai A, Tsegaye G, Ullah I, Ullah S, Umeokonkwo C, Unnikrishnan B, Vardavas C, Violante F, Vo B, Wado Y, Waheed Y, Wamai R, Wang Y, Ward P, Werdecker A, Wickramasinghe N, Wijeratne T, Wiysonge C, Wondmeneh T, Yamada T, Yaya S, Yeshaw Y, Yeshitila Y, Yilma M, Yip P, Yonemoto N, Yosef T, Yusefzadeh H, Zaidi S, Zaki L, Zamanian M, Zastrozhin M, Zastrozhina A, Zewdie D, Zhang Y, Zhang Z, Ziapour A, Hay S, Dwyer-Lindgren L. Subnational mapping of HIV incidence and mortality among individuals aged 15–49 years in sub-Saharan Africa, 2000–18: a modelling study. The Lancet HIV 2021, 8: e363-e375. PMID: 34087097, PMCID: PMC8187986, DOI: 10.1016/s2352-3018(21)00051-5.Peer-Reviewed Original ResearchConceptsHIV incidenceAntiretroviral therapyNew casesHIV mortalityHIV prevalenceProgress of preventionAntenatal care clinicsHIV prevalence dataSecond-level administrative unitsSaharan AfricaNumber of deathsHIV burdenCare clinicsSeroprevalence surveyMortality rateNew infectionsPrevalence dataMortalityHealth resourcesIncidenceMelinda Gates FoundationProjection PackageTreatment estimatesDeathSecond administrative levelDifference in HIV testing behavior by injection status, among users of illicit drugs
Gordon KS, Chiasson MA, Hoover DR, Martins SS, Wilson PA, Lewis CF. Difference in HIV testing behavior by injection status, among users of illicit drugs. AIDS Care 2021, 34: 776-783. PMID: 33856945, DOI: 10.1080/09540121.2021.1913716.Peer-Reviewed Original ResearchConceptsHIV testing behaviorsHIV testingTesting behaviorSex networksHuman immunodeficiency virus (HIV) infectionInjection statusNon-injected drugsImmunodeficiency virus infectionIllicit drugsCross-sectional designEmotional supportHIV prevalenceSocial network characteristicsHIV epidemicInjected drugsVirus infectionCondomless sexHeroin useAnalytic sampleNegative binomial regression modelsBinomial regression modelsDrugsPWNDRegression modelsStatus
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply